Sobi's Emapalumab-lzsg Granted FDA Fast Track Designation for Macrophage Activation Syndrome
May 25, 2024
Sobi Invest Information
Sobi to Unveil Myelofibrosis Treatment Data at ASCO 2024
May 25, 2024